Table 2.
Total Modified Overt Aggression Scale Score During the Study Period in the 3 Medication Groups as a Function of Low and High Baseline Scores on the Positive and Negative Syndrome Scale Depression Factor and on the Barratt Impulsiveness, Version 11a
| Barratt Impulsiveness | Depression | Medication Groups | Pairwise Comparisons Between Medications | ||||
|---|---|---|---|---|---|---|---|
| Clozapine N = 31, M (SE) | Olanzapine N = 36, M (SE) | Haloperidol N = 34, M (SE) | CLO-OLZ | CLO-HAL | OLZ-HAL | ||
| t (P) | t (P) | t (P) | |||||
| Low | Low | 10.6 (0.7) | 16.6 (0.9) | 14.1 (1.0) | −5.6 (<.001) | −3.2 (<.01) | 1.9 (.06) |
| High | 25.9 (3.5) | 52.1 (2.7) | 66.0 (5.2) | −4.9 (<.001) | −6.1 (<.001) | −2.5 (.01) | |
| High | Low | 10.0 (0.8) | 12.1 (0.9) | 16.9 (1.0) | −1.9 (.06) | −5.6 (<.001) | −3.6 (<.001) |
| High | 47.2 (3.5) | 48.1 (3.4) | 85.9 (4.8) | −0.2 (.8) | −6.7 (<.001) | −6.4 (<.001) | |
Note: CLO, clozapine; OLZ, olanzapine; HAL, haloperidol.
aHigh and low are defined as ± half an SD from the mean.